Course info
Sections
General
0 activities
Education Program
0 activities
A Little Less Conversation, a Little More Action: An Outcome Equity Roadmap for Children and AYAs With Leukemia and Lymphoma
3 activities
A Shifting Landscape: Treatment of MCL
4 activities
ALPS, CVID, and LGL: When Autoimmune Cytopenias Are a Marker of Underlying Immune Disease
4 activities
AML M&Ms: How to Integrate Mutations and MRD Data
4 activities
Addressing Unmet Needs in T Cell Lymphomas
4 activities
Adult ALL Advancements: Optimizing Cure in 2024
4 activities
Adult CAR-T Outcomes: Beyond the Acronyms (OS, PFS, CRS, ICANS)
4 activities
Anticoagulation SOS: Navigating Monitoring Conundrums
4 activities
Beyond TTP: “Atypical” TMAs for the Hematologist
4 activities
Challenges and Opportunities of Sickle Cell Care in Africa
4 activities
Challenges in Cancer-Associated Thrombosis
4 activities
Chasing Zebras: Navigating Rare Myeloid Neoplasms
4 activities
Follicular Lymphoma: Playing the Long Game
4 activities
HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia
4 activities
Handling Bad News: How to Best Manage TP53 Myeloid Disease?
4 activities
Hematologic Challenges at the End-of-Life
4 activities
Hematologic Management of the Patient with Heavy Menstrual Bleeding
4 activities
Integrating New Therapies into the Management of Classical Heme Disorders
3 activities
Ironing Out the Wrinkles: Managing Iron Overload in Different Clinical Scenarios
4 activities
It's a Different World: CLL 2024
4 activities
MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
4 activities
Monoclonal Gammopathies: When the Clone Is More Than a Positive Laboratory Finding
4 activities
Moving the Needle in Hodgkin Lymphoma
4 activities
Newly Diagnosed Multiple Myeloma: Many Choices and More Questions
4 activities
Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
4 activities
Optimizing Non-Curative Therapies for Sickle Cell Disease
4 activities
Overcoming Post-transplant Relapse: How to Win the Battle Royale
3 activities
Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
4 activities
The Expanding Landscape of Treatment for ITP
4 activities
Vascular Anomalies, Vascular Malformations, and the Role of the Hematologist
4 activities
30
87